The way of O: phenomenology of psychedelic use and the path to ultimate reality

References

• Aday, J. S., Davis, A. K., Mitzkovitz, C. M., Bloesch, E. K., & Davoli, C. C. (2021). Predicting reactions to psychedelic drugs: A systematic review of states and traits related to acute drug effects. ACS Pharmacology and Translational Science, 4(2), 424–435. https://doi.org/10.1021/acsptsci.1c00014
   PubMedGoogle Scholar
• Albaugh, B. J., & Anderson, P. O. (1974). Peyote in the treatment of alcoholism among American Indians. The American Journal of Psychiatry, 131(11), 1247–1250. https://doi.org/10.1176/ajp.131.11.1247
   PubMed Web of Science ®Google Scholar
• Alisobahni, A. K., & Corstorphine, G. J. (2019). Introduction. In A. K. Alisobhani & G. J. Corstorphine (Eds.), Explorations in Bion’s “O”: Everything we know nothing about (pp. 175–183). Routledge.
   Google Scholar
• Allen, J., Dames, S. S., Foldi, C. J., & Shultz, S. R. (2024). Psychedelics for acquired brain injury: A review of molecular mechanisms and therapeutic potential. Molecular Psychiatry, 29(3), 671–685. https://doi.org/10.1038/s41380-023-02360-0
   PubMedGoogle Scholar
• Armstrong, S. B., Xin, Y., Sepeda, N. D., Polanco, M., Averill, L. A., & Davis, A. K. (2023). Prospective associations of psychedelic treatment for co-occurring alcohol misuse and posttraumatic stress symptoms among United States special operations forces veterans. Military Psychology, 36(2), 184–191. https://doi.org/10.1080/08995605.2022.2156200
   PubMed Web of Science ®Google Scholar
• Baerentsen, K. B., Stødkilde Jørgensen, H., Sommerlund, B., Hartmann, T., Damsgaard-Madsen, J., Fosnaes, M., & Green, A. C. (2010). An investigation of brain processes supporting meditation. Cognitive Processing, 11(1), 57–84. https://doi.org/10.1007/s10339-009-0342-3
   PubMed Web of Science ®Google Scholar
• Barrett, F. S., Doss, M. K., Sepeda, N. D., Pekar, J. J., & Griffiths, R. R. (2020). Emotions and brain function are altered up to one month after a single high dose of psilocybin. Scientific Reports, 10(1), 2214. https://doi.org/10.1038/s41598-020-59282-y
   PubMed Web of Science ®Google Scholar
• Barrett, K. (2022). Psychedelic psychodynamics: Relational knowing and the unthought known. Psychoanalytic Dialogues, 32(5), 484–496. https://doi.org/10.1080/10481885.2022.2106141
   Web of Science ®Google Scholar
• Bergstein, A. (2009). On boredom: A close encounter with encapsulated parts of the psyche. International Journal of Psychoanalysis, 90(3), 613–631. https://doi.org/10.1111/j.1745-8315.2009.00150.x
   PubMed Web of Science ®Google Scholar
• Bergstein, A. (2022). “Truth shall spring out of the earth … ”: The analyst as gatherer of sense impressions. International Journal of Psychoanalysis, 103(2), 246–263. https://doi.org/10.1080/00207578.2021.2010561
   PubMed Web of Science ®Google Scholar
• Bicego, A., Cassol, H., Simon, J., Fritz, P., Abagnale, S., Vanhaudenhuyse, A., Laureys, S., & Martial, C. (2023). Personality traits and pattern of beliefs of near-death(-like) experiencers. Frontiers in Human Neuroscience, 17, 1124739. https://doi.org/10.3389/fnhum.2023.1124739
   PubMed Web of Science ®Google Scholar
• Bion, W. (1963/2018). Elements of psychoanalysis. Routledge.
   Google Scholar
• Bion, W. (1965/1984). Transformations. Routledge.
   Google Scholar
• Bion, W. (1970/2004). Attention and interpretation. Rowman & Littlefield Publishers, Inc.
   Google Scholar
• Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P. C., & Strassman, R. J. (2015). Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study. Journal of Psychopharmacology (Oxford, England), 29(3), 289–299. https://doi.org/10.1177/0269881114565144
   PubMed Web of Science ®Google Scholar
• Buot, A., Pallares, C., Oganesyan, A., Dauré, C., Bonnelle, V., Burguière, E., Dos Santos, J. F. A., N’Diaye, K., Ljuslin, M., Smith, P., Verroust, V., Wyplosz, B., Morgiève, M., & Mallet, L. (2023). Improvement in OCD symptoms associated with serotoninergic psychedelics: A retrospective online survey. Scientific Reports, 13(1), 13378. https://doi.org/10.1038/s41598-023-39812-0
   PubMed Web of Science ®Google Scholar
• Calder, A. E., & Hasler, G. (2023). Towards an understanding of psychedelic-induced neuroplasticity. Neuropsychopharmacology Reviews, 48(1), 104–112. https://doi.org/10.1038/s41386-022-01389-z
   PubMed Web of Science ®Google Scholar
• Carhart-Harris, R. L., Chandaria, S., Erritzoe, D. E., Gazzaley, A., Girn, M., Kettner, H., Mediano, P. A. M., Nutt, D. J., Rosas, F. E., Roseman, L., Timmermann, C., Weiss, B., Zeifman, R. J., & Friston, K. J. (2023). Canalization and plasticity in psychopathology. Neuropharmacology, the Neuropharmacology of Social Behavior: From Bench to Bedside, 226, 109398. https://doi.org/10.1016/j.neuropharm.2022.109398
   Google Scholar
• Carhart-Harris, R. L., Friston, K. J., & Barker, E. L. (2019). REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics. Pharmacological Reviews, 71(3), 316–344. https://doi.org/10.1124/pr.118.017160
   PubMed Web of Science ®Google Scholar
• Carhart-Harris, R. L., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., Martell, J., Blemings, A., Erritzoe, D., & Nutt, D. J. (2021). Trial of psilocybin versus escitalopram for depression. New England Journal of Medicine, 384(15), 1402–1411. https://doi.org/10.1056/NEJMoa2032994
   PubMed Web of Science ®Google Scholar
• Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., Tagliazucchi, E., Schenberg, E. E., Nest, T., Orban, C., Leech, R., Williams, L. T., Williams, T. M., Bolstridge, M., Sessa, B., McGonigle, J., Sereno, M. I., Nichols, D. & Nutt, D. J. (2016). Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proceedings of the National Academy of Sciences, 113(17), 4853–4858. https://doi.org/10.1073/pnas.1518377113
   PubMed Web of Science ®Google Scholar
• Carhart-Harris, R. L., Roseman, L., Bolstridge, M., Demetriou, L., Pannekoek, J. N., Wall, M. B., Tanner, M., Kaelen, M., McGonigle, J., Murphy, K., Leech, R., Curran, H. V., & Nutt, D. J. (2017). Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms. Scientific Reports, 7(1), 13187. https://doi.org/10.1038/s41598-017-13282-7
   PubMedGoogle Scholar
• Castelo Filho, C. (2019). On the verge of “Madness”: Creativity and the fear of insanity. In A. K. Alisobhani & G. J. Corstorphine (Eds.), Explorations in Bion’s “O”: Everything we know nothing about (pp. 175–183). Routledge.
   Google Scholar
• Cherian, K. N., Keynan, J. N., Anker, L., Faerman, A., Brown, R. E., Shamma, A., Keynan, O., Coetzee, J. P., Batail, J. M., Phillips, A., Bassano, N. J., Sahlem, G. L., Inzunza, J., Millar, T., Dickinson, J., Rolle, C. E., Keller, J., Adamson, M., Kratter, I. H., & Williams, N. R. (2024). Magnesium-ibogaine therapy in veterans with traumatic brain injuries. Nature Medicine, 30(2), 373–381. https://doi.org/10.1038/s41591-023-02705-w
   PubMed Web of Science ®Google Scholar
• Cooper, P. C. (2016). Zen musings on Bion’s “O” and “K”. Psychoanalytic Review, 103(4), 515–538. https://doi.org/10.1521/prev.2016.103.4.515
   PubMedGoogle Scholar
• Desseilles, M., Dang-Vu, T. T., Sterpenich, V., & Schwartz, S. (2011). Cognitive and emotional processes during dreaming: A neuroimaging view. Consciousness and Cognition, 20(4), 998–1008. https://doi.org/10.1016/j.concog.2010.10.005
   PubMed Web of Science ®Google Scholar
• Fischman, L. G. (2019). Seeing without self: Discovering new meaning with psychedelic-assisted psychotherapy. Neuropsychoanalysis, 21(2), 53–78. https://doi.org/10.1080/15294145.2019.1689528
   Google Scholar
• Frecska, E., Szabo, A., Winkelman, M. J., Luna, L. E., & McKenna, D. J. (2013). A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity. Journal of Neural Transmission, 120(9), 1295–1303. https://doi.org/10.1007/s00702-013-1024-y
   PubMed Web of Science ®Google Scholar
• Goldsmith, J. S. (1959). The art of spiritual healing. Acropolis Books.
   Google Scholar
• Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology (Oxford, England), 30(12), 1181–1197. https://doi.org/10.1177/0269881116675513
   PubMed Web of Science ®Google Scholar
• Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., Jesse, R., MacLean, K. A., Barrett, F. S., Cosimano, M. P., & Klinedinst, M. A. (2018). Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. Journal of Psychopharmacology (Oxford, England), 32(1), 49–69. https://doi.org/10.1177/0269881117731279
   PubMed Web of Science ®Google Scholar
• Grimm, O., Kraehenmann, R., Preller, K. H., Seifritz, E., & Vollenweider, F. X. (2018). Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology, 28(6), 691–700. https://doi.org/10.1016/j.euroneuro.2018.03.016
   PubMed Web of Science ®Google Scholar
• Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011). Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Archives of General Psychiatry, 68(1), 71–78. https://doi.org/10.1001/archgenpsychiatry.2010.116
   PubMed Web of Science ®Google Scholar
• Grof, S. (1975/2021). Realms of the human unconscious. Souvenir Press.
   Google Scholar
• Grof, S. (1980). LSD psychotherapy. Hunter House.
   Google Scholar
• Grotstein, J. (1997). Bion, the pariah of ‘O’. British Journal of Psychotherapy, 14(1), 77–90. https://doi.org/10.1111/j.1752-0118.1997.tb00354.x
   Google Scholar
• Grupe, D. W., & Nitschke, J. B. (2013). Uncertainty and anticipation in anxiety: An integrated neurobiological and psychological perspective. Nature Reviews Neuroscience, 14(7), 488–501. https://doi.org/10.1038/nrn3524
   PubMed Web of Science ®Google Scholar
• Guss, J. (2022). A psychoanalytic perspective on psychedelic experience. Psychoanalytic Dialogues, 32(5), 452–468. https://doi.org/10.1080/10481885.2022.2106140
   Web of Science ®Google Scholar
• Hale, J. R., White, T. P., Mayhew, S. D., Wilson, R. S., Rollings, D. T., Khalsa, S., Arvanitis, T. N., & Bagshaw, A. P. (2016). Altered thalamocortical and intra-thalamic functional connectivity during light sleep compared with wake. Neuroimage: Reports, 125, 657–667. https://doi.org/10.1016/j.neuroimage.2015.10.041
   Google Scholar
• Halpern, J. H. (2003). Hallucinogens: An update. Current Psychiatry Reports, 5(5), 347–354. https://doi.org/10.1007/s11920-003-0067-4
   PubMedGoogle Scholar
• Harris, E. (2024). Psychedelic tied to better function in veterans with head injuries. Jama, 331(5), 385. https://doi.org/10.1001/jama.2023.27436
   Web of Science ®Google Scholar
• Healy, C. J. (2021). The acute effects of classic psychedelics on memory in humans. Psychopharmacology (Berl), 238(3), 639–653. https://doi.org/10.1007/s00213-020-05756-w
   PubMed Web of Science ®Google Scholar
• Hendricks, P. S., Clark, C. B., Johnson, M. W., Fontaine, K. R., & Cropsey, K. L. (2014). Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision. Journal of Psychopharmacology (Oxford, England), 28(1), 62–66. https://doi.org/10.1177/0269881113513851
   PubMed Web of Science ®Google Scholar
• Hobson, J. A., & Pace-Schott, E. F. (2002). The cognitive neuroscience of sleep: Neuronal systems, consciousness and learning. Nature Reviews Neuroscience, 3(9), 679–693. https://doi.org/10.1038/nrn915
   PubMed Web of Science ®Google Scholar
• Honk, L., Stenfors, C. U. D., Goldberg, S. B., Hendricks, P. S., Osika, W., Dourron, H. M., Lebedev, A., Petrovic, P., & Simonsson, O. (2024). Longitudinal associations between psychedelic use and psychotic symptoms in the United States and the United Kingdom. Journal of Affective Disorders, 351, 194–201. https://doi.org/10.1016/j.jad.2024.01.197
   PubMed Web of Science ®Google Scholar
• Isham, A., Elf, P., & Jackson, T. (2022). Self-transcendent experiences as promoters of ecological wellbeing? Exploration of the evidence and hypotheses to be tested. Frontiers in Psychology, 13, 1051478. https://doi.org/10.3389/fpsyg.2022.1051478
   PubMed Web of Science ®Google Scholar
• Ives-Deliperi, V. L., Solms, M., & Meintjes, E. M. (2011). The neural substrates of mindfulness: An fMRI investigation. Social Neuroscience, 6(3), 231–242. https://doi.org/10.1080/17470919.2010.513495
   PubMed Web of Science ®Google Scholar
• Johnson, M. W. (2021). Consciousness, religion, and gurus: Pitfalls of psychedelic medicine. ACS Pharmacology and Translational Science, 4(2), 578–581. https://doi.org/10.1021/acsptsci.0c00198
   PubMedGoogle Scholar
• Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014). Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology (Oxford, England), 28(11), 983–992. https://doi.org/10.1177/0269881114548296
   PubMed Web of Science ®Google Scholar
• Ko, K., Knight, G., Rucker, J. J., & Cleare, A. J. (2022). Psychedelics, mystical experience, and therapeutic efficacy: A systematic review. Frontiers in Psychiatry, 13, 917199. https://doi.org/10.3389/fpsyt.2022.917199
   PubMed Web of Science ®Google Scholar
• Kohon, S. J. (2014). Making contact with the primitive mind: The contact-barrier, beta-elements and the drives. International Journal of Psychoanalysis, 95(2), 245–270. https://doi.org/10.1111/1745-8315.12140
   PubMed Web of Science ®Google Scholar
• Kopra, E. I., Ferris, J. A., Rucker, J. J., McClure, B., Young, A. H., Copeland, C. S., & Winstock, A. R. (2022). Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD). Journal of Psychopharmacology (Oxford, England), 36(8), 956–964. https://doi.org/10.1177/02698811221099650
   PubMed Web of Science ®Google Scholar
• Kraehenmann, R. (2017). Dreams and psychedelics: Neurophenomenological comparison and therapeutic implications. Current Neuropharmacology, 15(7), 1032–1042. https://doi.org/10.2174/1573413713666170619092629
   PubMed Web of Science ®Google Scholar
• Levin, A. W., Lancelotta, R., Sepeda, N. D., Gukasyan, N., Nayak, S., Wagener, T. L., Barrett, F. S., Griffiths, R. R., Davis, A. K., & Covington, H. (2024). The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder. PLOS ONE, 19(3), e0300501. https://doi.org/10.1371/journal.pone.0300501
   PubMed Web of Science ®Google Scholar
• Majić, T., Schmidt, T. T., & Gallinat, J. (2015). Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences? Journal of Psychopharmacology (Oxford, England), 29(3), 241–253. https://doi.org/10.1177/0269881114568040
   PubMed Web of Science ®Google Scholar
• Marrocu, A., Kettner, H., Weiss, B., Zeifman, R. J., Erritzoe, D., & Carhart-Harris, R. L. (2024). Psychiatric risks for worsened mental health after psychedelic use. Journal of Psychopharmacology (Oxford, England), 38(3), 225–235. https://doi.org/10.1177/02698811241232548
   PubMed Web of Science ®Google Scholar
• McGlothlin, W., Cohen, S., & McGlothlin, M. S. (1967). Long lasting effects of LSD on normals. Archives of General Psychiatry, 17(5), 521–532. https://doi.org/10.1001/archpsyc.1967.01730290009002
   PubMed Web of Science ®Google Scholar
• Mertens, L. J., Wall, M. B., Roseman, L., Demetriou, L., Nutt, D. J., & Carhart-Harris, R. L. (2020). Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression. Journal of Psychopharmacology (Oxford, England), 34(2), 167–180. https://doi.org/10.1177/0269881119895520
   PubMed Web of Science ®Google Scholar
• Moreno, F. A., Wiegand, C. B., Taitano, E. K., & Delgado, P. L. (2006). Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. The Journal of Clinical Psychiatry, 67(11), 1735–1740. https://doi.org/10.4088/jcp.v67n1110
   PubMed Web of Science ®Google Scholar
• Murphy, R., Kettner, H., Zeifman, R., Giribaldi, B., Kartner, L., Martell, J., Read, T., Murphy-Beiner, A., Baker-Jones, M., Nutt, D., Erritzoe, D., Watts, R., & Carhart-Harris, R. (2021). Therapeutic alliance and rapport modulate responses to psilocybin assisted therapy for depression. Frontiers in Pharmacology, 12, 788155. https://doi.org/10.3389/fphar.2021.788155
   PubMed Web of Science ®Google Scholar
• Nelson, C. A., 3rd, & Gabard-Durnam, L. J. (2020). Early adversity and critical periods: Neurodevelopmental consequences of violating the expectable environment. Trends in Neurosciences, 43(3), 133–143. https://doi.org/10.1016/j.tins.2020.01.002
   PubMed Web of Science ®Google Scholar
• Pahnke, W. N. (1969). The psychedelic mystical experience in the human encounter with death. The Harvard Theological Review, 62(1), 1–21. https://doi.org/10.1017/S0017816000027577
   Google Scholar
• Peck, S. K., Shao, S., Gruen, T., Yang, K., Babakanian, A., Trim, J., Finn, D. M., & Kaye, W. H. (2023). Psilocybin therapy for females with anorexia nervosa: A phase 1, open-label feasibility study. Nature Medicine, 29(8), 1947–1953. https://doi.org/10.1038/s41591-023-02455-9
   PubMed Web of Science ®Google Scholar
• Peill, J., Marguilho, M., Erritzoe, D., Barba, T., Greenway, K. T., Rosas, F., Timmermann, C., & Carhart-Harris, R. (2024). Psychedelics and the ‘inner healer’: Myth or mechanism? Journal of Psychopharmacology (Oxford, England), 38(5), 417–424. https://doi.org/10.1177/02698811241239206
   PubMed Web of Science ®Google Scholar
• Pilozzi, A., Foster, S., Mischoulon, D., Fava, M., & Huang, X. (2023). A brief review on the potential of psychedelics for treating Alzheimer’s disease and related depression. International Journal of Molecular Sciences, 24(15), 12513. https://doi.org/10.3390/ijms241512513
   PubMed Web of Science ®Google Scholar
• Podrebarac, S. K., O’Donnell, K. C., Mennenga, S. E., Owens, L. T., Malone, T. C., Duane, J. H., & Bogenschutz, M. P. (2021). Spiritual experiences in psychedelic-assisted psychotherapy: Case reports of communion with the divine, the departed, and saints in research using psilocybin for the treatment of alcohol dependence. Spirituality in Clinical Practice, 8(3), 177–187. https://doi.org/10.1037/scp0000242
   Web of Science ®Google Scholar
• Preller, K. H., Burt, J. B., Ji, J. L., Schleifer, C. H., Adkinson, B. D., Stämpfli, P., Seifritz, E., Repovs, G., Krystal, J. H., Murray, J. D., Vollenweider, F. X., & Anticevic, A. (2018). Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor. Elife, 7. https://doi.org/10.7554/eLife.35082
   PubMed Web of Science ®Google Scholar
• Preller, K. H., & Vollenweider, F. X. (2018). Phenomenology, structure, and dynamic of psychedelic states. Current Topics in Behavioral Neurosciences, 36, 221–256. https://doi.org/10.1007/7854_2016_459
   PubMedGoogle Scholar
• Reiner, A. (2016). The truth object: Growing the god within. In H. Levine & G. Civitarese (Eds.), The W. R. Bion tradition (pp. 155–169). Karnac.
   Google Scholar
• Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., Su, Z., Corby, P., & Schmidt, B. L. (2016). Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. Journal of Psychopharmacology (Oxford, England), 30(12), 1165–1180. https://doi.org/10.1177/0269881116675512
   PubMed Web of Science ®Google Scholar
• Rundel, M. (2022). Psychedelic psychoanalysis: Transformations of the self. Psychoanalytic Dialogues, 32(5), 469–483. https://doi.org/10.1080/10481885.2022.2106139
   Web of Science ®Google Scholar
• Saeger, H. N., & Olson, D. E. (2022). Psychedelic-inspired approaches for treating neurodegenerative disorders. Journal of Neurochemistry, 162(1), 109–127. https://doi.org/10.1111/jnc.15544
   PubMed Web of Science ®Google Scholar
• Sanches, R. F., de Lima Osório, F., Dos Santos, R. G., Macedo, L. R., Maia de Oliveira, J. P., Wichert-Ana, L., de Araujo, D. B., Riba, J., Crippa, J. A., & Hallak, J. E. (2016). Antidepressant effects of a single dose of Ayahuasca in patients with recurrent depression: A SPECT study. Journal of Clinical Psychopharmacology, 36(1), 77–81. https://doi.org/10.1097/jcp.0000000000000436
   PubMed Web of Science ®Google Scholar
• Scarone, S., Manzone, M. L., Gambini, O., Kantzas, I., Limosani, I., D’Agostino, A., & Hobson, J. A. (2008). The dream as a model for psychosis: An experimental approach using bizarreness as a cognitive marker. Schizophrenia Bulletin, 34(3), 515–522. https://doi.org/10.1093/schbul/sbm116
   PubMed Web of Science ®Google Scholar
• Smigielski, L., Kometer, M., Scheidegger, M., Krähenmann, R., Huber, T., & Vollenweider, F. X. (2019). Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat. Scientific Reports, 9(1), 14914. https://doi.org/10.1038/s41598-019-50612-3
   PubMed Web of Science ®Google Scholar
• Steiner, J. (2008). Transference to the analyst as an excluded observer. International Journal of Psychoanalysis, 89(1), 39–54. https://doi.org/10.1111/j.1745-8315.2007.00005.x
   PubMed Web of Science ®Google Scholar
• Szigeti, B., & Heifets, B. D. (2024). Expectancy effects in psychedelic trials. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 9(5), 512–521. https://doi.org/10.1016/j.bpsc.2024.02.004
   PubMedGoogle Scholar
• Takesian, A. E., & Hensch, T. K. (2013). Balancing plasticity/stability across brain development. Progress in Brain Research, 207, 3–34. https://doi.org/10.1016/b978-0-444-63327-9.00001-1
   PubMed Web of Science ®Google Scholar
• Tap, S. C. (2024). The potential of 5-methoxy-N,N-dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action. Addiction Biology, 29(4), e13386. https://doi.org/10.1111/adb.13386
   PubMed Web of Science ®Google Scholar
• Timmermann, C., Kettner, H., Letheby, C., Roseman, L., Rosas, F. E., & Carhart-Harris, R. L. (2021). Psychedelics alter metaphysical beliefs. Scientific Reports, 11(1), 22166. https://doi.org/10.1038/s41598-021-01209-2
   PubMed Web of Science ®Google Scholar
• Timmermann, C., Roseman, L., Williams, L., Erritzoe, D., Martial, C., Cassol, H., Laureys, S., Nutt, D., & Carhart-Harris, R. (2018). DMT models the near-death experience. Frontiers in Psychology, 9, 1424. https://doi.org/10.3389/fpsyg.2018.01424
   PubMed Web of Science ®Google Scholar
• Vargas, M. V., Meyer, R., Avanes, A. A., Rus, M., & Olson, D. E. (2021). Psychedelics and other psychoplastogens for treating mental illness. Frontiers in Psychiatry, 12, 727117. https://doi.org/10.3389/fpsyt.2021.727117
   PubMed Web of Science ®Google Scholar
• Vollenweider, F. X., & Kometer, M. (2010). The neurobiology of psychedelic drugs: Implications for the treatment of mood disorders. Nature Reviews Neuroscience, 11(9), 642–651. https://doi.org/10.1038/nrn2884
   PubMed Web of Science ®Google Scholar
• Vollenweider, F. X., & Smallridge, J. W. (2022). Classic psychedelic drugs: Update on biological mechanisms. Pharmacopsychiatry, 55(3), 121–138. https://doi.org/10.1055/a-1721-2914
   PubMedGoogle Scholar
• Watts, R., Day, C., Krzanowski, J., Nutt, D., & Carhart-Harris, R. (2017). Patients’ accounts of increased “connectedness” and “acceptance” after psilocybin for treatment-resistant depression. Journal of Humanistic Psychology, 57(5), 520–564. https://doi.org/10.1177/0022167817709585
   Web of Science ®Google Scholar
• Wetmore, R. J. (1963). The role of grief in psycho-analysis. International Journal of Psychoanalysis, 44, 97–103.
   PubMed Web of Science ®Google Scholar
• Wolf, G., Singh, S., Blakolmer, K., Lerer, L., Lifschytz, T., Heresco-Levy, U., Lotan, A., & Lerer, B. (2023). Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation. Molecular Psychiatry, 28(1), 44–58. https://doi.org/10.1038/s41380-022-01832-z
   PubMed Web of Science ®Google Scholar